Early hematopoiesis in multiple sclerosis patients

J Neuroimmunol. 2016 Oct 15:299:158-163. doi: 10.1016/j.jneuroim.2016.09.004. Epub 2016 Sep 13.

Abstract

Contemporary evidence supports that MS immunopathology starts in the peripheral lymphatic system. However, the site and character of crucial initiating events are unknown. We examined subsets of the first stages of blood cells in the bone marrow of 9 MS patients and 11 neurologically healthy controls using FACS analysis. The proportion of natural killer T cells was lower (P=0.045) in the bone marrow of MS patients, but proportions of hematogenous stem cells, myeloblasts, and B cell precursor subsets in the bone marrow did not differ between MS patients and controls. In this pilot study with a limited number of samples we found no deviation of the early B cell lineage in bone marrow from MS patients.

Keywords: B cell; Bone marrow; FACS; Multiple sclerosis; NKT cell; Precursor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • B-Lymphocytes / immunology
  • B-Lymphocytes / metabolism
  • Bone Marrow Cells / immunology
  • Bone Marrow Cells / metabolism
  • Female
  • Hematopoiesis / physiology*
  • Humans
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism
  • Male
  • Middle Aged
  • Multiple Sclerosis / blood*
  • Multiple Sclerosis / diagnosis
  • Multiple Sclerosis / immunology*
  • Pilot Projects
  • Young Adult